At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 4 enrolled
Drug / intervention
Nesiritide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
AdventHealth Translational Research Institute·interventional·Posted Nov 7, 2013·Updated Feb 14, 2018
In Brief
A Phase 1 clinical trial evaluating Nesiritide and Saline for Obesity and 3 related conditions. Completed, enrolled 4 participants across 1 site.
Detailed Summary
The purpose of this study is to collect data to help researchers better understand the various causes of obesity, which may lead to the development of new obesity treatment options.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Cardiovascular Disease, Hypertension, Diabetes
CountriesUnited States
CollaboratorsSanford-Burnham Medical Research Institute
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedNov 2013
Primary CompletionFeb 2016
Study CompletionFeb 2017
TodayJul 2026
First PostedNov 7, 2013
Enrollment StartNov 1, 2013
Primary CompletionFeb 15, 2016
Study CompletionFeb 28, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.7 years ago
Interventions
Nesiritidedrug
Salinedrug